ID
36027
Beschreibung
Study ID: 101468/198 Clinical Study ID: 101468/198 Study Title:An open, randomised, crossover, healthy volunteer study to compare the PK and tolerability of ropinirole as 3 different new formulations with the standard marketed formulation and to study the effects of a high fat meal on a new formulation Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 1 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Modutab,ZIPEREVE,ZEPREVE,REPREVE,ADARTREL,REQUIP,Zygara; Zygara,ZIPEREVE,ZEPREVE,Requip Depot,REQUIP,REPREVE,Modutab,ADARTREL Study Indication : Restless Legs Syndrome The Study consists of a Screening, 5 Sessions each with 2 days and a Follow-up. This document contains the concomitant medication form. It has to be filled in if the subject takes concomitant medication during the study trial. Please complete drug section for all drugs (including OTC)/ vaccines taken by mother within 3 months prior or during pregnancy.
Stichworte
Versionen (1)
- 09.04.19 09.04.19 -
Rechteinhaber
GlaxoSmithKline
Hochgeladen am
9. April 2019
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY-NC 3.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Comparison of pharmacokinetic and tolerability of ropinirole in healthy adults, 101468/198
Concomitant Medication
- StudyEvent: ODM
Beschreibung
Concomitant Medication
Alias
- UMLS CUI-1
- C2347852
Beschreibung
If 'YES', please record all medications used below. Where appropriate, medical conditions should be recorded on the Adverse Experiences Form, utilzing the same terminology. If a medication has had a dosage change it must be recorded with the start and stop date.
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C2347852
- UMLS CUI [1,2]
- C2169461
Beschreibung
(Trade Name Preferred)
Datentyp
text
Alias
- UMLS CUI [1]
- C2360065
Beschreibung
Single Dose/Unit
Datentyp
text
Alias
- UMLS CUI [1]
- C1960417
Beschreibung
Frequency of this Dose
Datentyp
text
Alias
- UMLS CUI [1]
- C3476109
Beschreibung
Other routes may be entered onto the form when appropriate, and will be coded prior to data entry.
Datentyp
text
Alias
- UMLS CUI [1]
- C0013153
Beschreibung
Indication
Datentyp
text
Alias
- UMLS CUI [1,1]
- C3146298
- UMLS CUI [1,2]
- C0013227
Beschreibung
day month year As a minimum the year must be stated.
Datentyp
date
Alias
- UMLS CUI [1]
- C2826734
Beschreibung
00:00-23:59
Datentyp
time
Alias
- UMLS CUI [1]
- C2826740
Beschreibung
day month year
Datentyp
date
Alias
- UMLS CUI [1]
- C2826744
Beschreibung
00:00-23:59
Datentyp
time
Alias
- UMLS CUI [1]
- C2826659
Beschreibung
Continuing at end of study
Datentyp
boolean
Alias
- UMLS CUI [1,1]
- C1553904
- UMLS CUI [1,2]
- C2983670
Ähnliche Modelle
Concomitant Medication
- StudyEvent: ODM
C2169461 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,2])
C2983670 (UMLS CUI [1,2])
Keine Kommentare